Naveen Yalamanchi - 13 Jun 2022 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Director
Signature
/s/ Martin Wilson, as attorney-in-fact
Issuer symbol
RCKT
Transactions as of
13 Jun 2022
Transactions value $
$0
Form type
4
Filing time
15 Jun 2022, 21:07:33 UTC
Previous filing
16 Jun 2021
Next filing
26 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCKT Stock Option (Right to Buy) Award $0 +47.7K $0.00 47.7K 13 Jun 2022 Common Stock 47.7K $10.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 47,745 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2023.

Remarks:

Exhibit 24: Power of Attorney